The global H1N1 Vaccines market was valued at US$ 4576.4 million in 2023 and is anticipated to reach US$ 5708.3 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.

H1N1 Vaccines Market

A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for H1N1 Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding H1N1 Vaccines.

Report Scope

The H1N1 Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global H1N1 Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the H1N1 Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of H1N1 Vaccines Market Report

Report Metric	Details
Report Name	H1N1 Vaccines Market
Accounted market size in 2023	US$ 4576.4 million
Forecasted market size in 2030	US$ 5708.3 million
CAGR	3.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Intramuscular Vaccines Intranasal Vaccines Intradermal Vaccines
Segment by Application	Influenza Meningococcal Cervical Cancer Pneumococcal Hepatitis Measles Mumps Rubella Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott, Baxter International, Sanofi, GSK, Pfizer, Mitsubishi Tanabe Pharma, Hualan Biological Engineering, Cipla, Merck, Sinovac Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of H1N1 Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of H1N1 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is H1N1 Vaccines Market growing?

Ans: The H1N1 Vaccines Market witnessing a CAGR of 3.2% during the forecast period 2024-2030.

What is the H1N1 Vaccines Market size in 2030?

Ans: The H1N1 Vaccines Market size in 2030 will be US$ 5708.3 million.

Who are the main players in the H1N1 Vaccines Market report?

Ans: The main players in the H1N1 Vaccines Market are Abbott, Baxter International, Sanofi, GSK, Pfizer, Mitsubishi Tanabe Pharma, Hualan Biological Engineering, Cipla, Merck, Sinovac Biotech

What are the Application segmentation covered in the H1N1 Vaccines Market report?

Ans: The Applications covered in the H1N1 Vaccines Market report are Influenza, Meningococcal, Cervical Cancer, Pneumococcal, Hepatitis, Measles, Mumps, Rubella, Others

What are the Type segmentation covered in the H1N1 Vaccines Market report?

Ans: The Types covered in the H1N1 Vaccines Market report are Intramuscular Vaccines, Intranasal Vaccines, Intradermal Vaccines

1 H1N1 Vaccines Market Overview

1.1 Product Overview and Scope of H1N1 Vaccines

1.2 H1N1 Vaccines Segment by Type

1.2.1 Global H1N1 Vaccines Market Value Comparison by Type (2024-2030)

1.2.2 Intramuscular Vaccines

1.2.3 Intranasal Vaccines

1.2.4 Intradermal Vaccines

1.3 H1N1 Vaccines Segment by Application

1.3.1 Global H1N1 Vaccines Market Value by Application: (2024-2030)

1.3.2 Influenza

1.3.3 Meningococcal

1.3.4 Cervical Cancer

1.3.5 Pneumococcal

1.3.6 Hepatitis

1.3.7 Measles

1.3.8 Mumps

1.3.9 Rubella

1.3.10 Others

1.4 Global H1N1 Vaccines Market Size Estimates and Forecasts

1.4.1 Global H1N1 Vaccines Revenue 2019-2030

1.4.2 Global H1N1 Vaccines Sales 2019-2030

1.4.3 Global H1N1 Vaccines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 H1N1 Vaccines Market Competition by Manufacturers

2.1 Global H1N1 Vaccines Sales Market Share by Manufacturers (2019-2024)

2.2 Global H1N1 Vaccines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global H1N1 Vaccines Average Price by Manufacturers (2019-2024)

2.4 Global H1N1 Vaccines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of H1N1 Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of H1N1 Vaccines, Product Type & Application

2.7 H1N1 Vaccines Market Competitive Situation and Trends

2.7.1 H1N1 Vaccines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest H1N1 Vaccines Players Market Share by Revenue

2.7.3 Global H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 H1N1 Vaccines Retrospective Market Scenario by Region

3.1 Global H1N1 Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global H1N1 Vaccines Global H1N1 Vaccines Sales by Region: 2019-2030

3.2.1 Global H1N1 Vaccines Sales by Region: 2019-2024

3.2.2 Global H1N1 Vaccines Sales by Region: 2025-2030

3.3 Global H1N1 Vaccines Global H1N1 Vaccines Revenue by Region: 2019-2030

3.3.1 Global H1N1 Vaccines Revenue by Region: 2019-2024

3.3.2 Global H1N1 Vaccines Revenue by Region: 2025-2030

3.4 North America H1N1 Vaccines Market Facts & Figures by Country

3.4.1 North America H1N1 Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America H1N1 Vaccines Sales by Country (2019-2030)

3.4.3 North America H1N1 Vaccines Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe H1N1 Vaccines Market Facts & Figures by Country

3.5.1 Europe H1N1 Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe H1N1 Vaccines Sales by Country (2019-2030)

3.5.3 Europe H1N1 Vaccines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific H1N1 Vaccines Market Facts & Figures by Country

3.6.1 Asia Pacific H1N1 Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific H1N1 Vaccines Sales by Country (2019-2030)

3.6.3 Asia Pacific H1N1 Vaccines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America H1N1 Vaccines Market Facts & Figures by Country

3.7.1 Latin America H1N1 Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America H1N1 Vaccines Sales by Country (2019-2030)

3.7.3 Latin America H1N1 Vaccines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa H1N1 Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa H1N1 Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa H1N1 Vaccines Sales by Country (2019-2030)

3.8.3 Middle East and Africa H1N1 Vaccines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global H1N1 Vaccines Sales by Type (2019-2030)

4.1.1 Global H1N1 Vaccines Sales by Type (2019-2024)

4.1.2 Global H1N1 Vaccines Sales by Type (2025-2030)

4.1.3 Global H1N1 Vaccines Sales Market Share by Type (2019-2030)

4.2 Global H1N1 Vaccines Revenue by Type (2019-2030)

4.2.1 Global H1N1 Vaccines Revenue by Type (2019-2024)

4.2.2 Global H1N1 Vaccines Revenue by Type (2025-2030)

4.2.3 Global H1N1 Vaccines Revenue Market Share by Type (2019-2030)

4.3 Global H1N1 Vaccines Price by Type (2019-2030)

5 Segment by Application

5.1 Global H1N1 Vaccines Sales by Application (2019-2030)

5.1.1 Global H1N1 Vaccines Sales by Application (2019-2024)

5.1.2 Global H1N1 Vaccines Sales by Application (2025-2030)

5.1.3 Global H1N1 Vaccines Sales Market Share by Application (2019-2030)

5.2 Global H1N1 Vaccines Revenue by Application (2019-2030)

5.2.1 Global H1N1 Vaccines Revenue by Application (2019-2024)

5.2.2 Global H1N1 Vaccines Revenue by Application (2025-2030)

5.2.3 Global H1N1 Vaccines Revenue Market Share by Application (2019-2030)

5.3 Global H1N1 Vaccines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Abbott

6.1.1 Abbott Corporation Information

6.1.2 Abbott Description and Business Overview

6.1.3 Abbott H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Abbott H1N1 Vaccines Product Portfolio

6.1.5 Abbott Recent Developments/Updates

6.2 Baxter International

6.2.1 Baxter International Corporation Information

6.2.2 Baxter International Description and Business Overview

6.2.3 Baxter International H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Baxter International H1N1 Vaccines Product Portfolio

6.2.5 Baxter International Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Corporation Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi H1N1 Vaccines Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 GSK

6.4.1 GSK Corporation Information

6.4.2 GSK Description and Business Overview

6.4.3 GSK H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GSK H1N1 Vaccines Product Portfolio

6.4.5 GSK Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Corporation Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Pfizer H1N1 Vaccines Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 Mitsubishi Tanabe Pharma

6.6.1 Mitsubishi Tanabe Pharma Corporation Information

6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview

6.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Product Portfolio

6.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates

6.7 Hualan Biological Engineering

6.6.1 Hualan Biological Engineering Corporation Information

6.6.2 Hualan Biological Engineering Description and Business Overview

6.6.3 Hualan Biological Engineering H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Hualan Biological Engineering H1N1 Vaccines Product Portfolio

6.7.5 Hualan Biological Engineering Recent Developments/Updates

6.8 Cipla

6.8.1 Cipla Corporation Information

6.8.2 Cipla Description and Business Overview

6.8.3 Cipla H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Cipla H1N1 Vaccines Product Portfolio

6.8.5 Cipla Recent Developments/Updates

6.9 Merck

6.9.1 Merck Corporation Information

6.9.2 Merck Description and Business Overview

6.9.3 Merck H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Merck H1N1 Vaccines Product Portfolio

6.9.5 Merck Recent Developments/Updates

6.10 Sinovac Biotech

6.10.1 Sinovac Biotech Corporation Information

6.10.2 Sinovac Biotech Description and Business Overview

6.10.3 Sinovac Biotech H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Sinovac Biotech H1N1 Vaccines Product Portfolio

6.10.5 Sinovac Biotech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 H1N1 Vaccines Industry Chain Analysis

7.2 H1N1 Vaccines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 H1N1 Vaccines Production Mode & Process

7.4 H1N1 Vaccines Sales and Marketing

7.4.1 H1N1 Vaccines Sales Channels

7.4.2 H1N1 Vaccines Distributors

7.5 H1N1 Vaccines Customers

8 H1N1 Vaccines Market Dynamics

8.1 H1N1 Vaccines Industry Trends

8.2 H1N1 Vaccines Market Drivers

8.3 H1N1 Vaccines Market Challenges

8.4 H1N1 Vaccines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Mitsubishi Tanabe Pharma

Hualan Biological Engineering

Cipla Ltd

Merck

SINOVAC BIOTECH

List of Tables

Table 1. Global H1N1 Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global H1N1 Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global H1N1 Vaccines Market Competitive Situation by Manufacturers in 2023

Table 4. Global H1N1 Vaccines Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global H1N1 Vaccines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global H1N1 Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global H1N1 Vaccines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market H1N1 Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of H1N1 Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of H1N1 Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of H1N1 Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of H1N1 Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global H1N1 Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in H1N1 Vaccines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global H1N1 Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global H1N1 Vaccines Sales by Region (2019-2024) & (K Units)

Table 18. Global H1N1 Vaccines Sales Market Share by Region (2019-2024)

Table 19. Global H1N1 Vaccines Sales by Region (2025-2030) & (K Units)

Table 20. Global H1N1 Vaccines Sales Market Share by Region (2025-2030)

Table 21. Global H1N1 Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global H1N1 Vaccines Revenue Market Share by Region (2019-2024)

Table 23. Global H1N1 Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global H1N1 Vaccines Revenue Market Share by Region (2025-2030)

Table 25. North America H1N1 Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America H1N1 Vaccines Sales by Country (2019-2024) & (K Units)

Table 27. North America H1N1 Vaccines Sales by Country (2025-2030) & (K Units)

Table 28. North America H1N1 Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America H1N1 Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe H1N1 Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe H1N1 Vaccines Sales by Country (2019-2024) & (K Units)

Table 32. Europe H1N1 Vaccines Sales by Country (2025-2030) & (K Units)

Table 33. Europe H1N1 Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe H1N1 Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific H1N1 Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific H1N1 Vaccines Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific H1N1 Vaccines Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific H1N1 Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific H1N1 Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America H1N1 Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America H1N1 Vaccines Sales by Country (2019-2024) & (K Units)

Table 42. Latin America H1N1 Vaccines Sales by Country (2025-2030) & (K Units)

Table 43. Latin America H1N1 Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America H1N1 Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa H1N1 Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa H1N1 Vaccines Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa H1N1 Vaccines Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa H1N1 Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa H1N1 Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global H1N1 Vaccines Sales (K Units) by Type (2019-2024)

Table 51. Global H1N1 Vaccines Sales (K Units) by Type (2025-2030)

Table 52. Global H1N1 Vaccines Sales Market Share by Type (2019-2024)

Table 53. Global H1N1 Vaccines Sales Market Share by Type (2025-2030)

Table 54. Global H1N1 Vaccines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global H1N1 Vaccines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global H1N1 Vaccines Revenue Market Share by Type (2019-2024)

Table 57. Global H1N1 Vaccines Revenue Market Share by Type (2025-2030)

Table 58. Global H1N1 Vaccines Price (USD/Unit) by Type (2019-2024)

Table 59. Global H1N1 Vaccines Price (USD/Unit) by Type (2025-2030)

Table 60. Global H1N1 Vaccines Sales (K Units) by Application (2019-2024)

Table 61. Global H1N1 Vaccines Sales (K Units) by Application (2025-2030)

Table 62. Global H1N1 Vaccines Sales Market Share by Application (2019-2024)

Table 63. Global H1N1 Vaccines Sales Market Share by Application (2025-2030)

Table 64. Global H1N1 Vaccines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global H1N1 Vaccines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global H1N1 Vaccines Revenue Market Share by Application (2019-2024)

Table 67. Global H1N1 Vaccines Revenue Market Share by Application (2025-2030)

Table 68. Global H1N1 Vaccines Price (USD/Unit) by Application (2019-2024)

Table 69. Global H1N1 Vaccines Price (USD/Unit) by Application (2025-2030)

Table 70. Abbott Corporation Information

Table 71. Abbott Description and Business Overview

Table 72. Abbott H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Abbott H1N1 Vaccines Product

Table 74. Abbott Recent Developments/Updates

Table 75. Baxter International Corporation Information

Table 76. Baxter International Description and Business Overview

Table 77. Baxter International H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Baxter International H1N1 Vaccines Product

Table 79. Baxter International Recent Developments/Updates

Table 80. Sanofi Corporation Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Sanofi H1N1 Vaccines Product

Table 84. Sanofi Recent Developments/Updates

Table 85. GSK Corporation Information

Table 86. GSK Description and Business Overview

Table 87. GSK H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. GSK H1N1 Vaccines Product

Table 89. GSK Recent Developments/Updates

Table 90. Pfizer Corporation Information

Table 91. Pfizer Description and Business Overview

Table 92. Pfizer H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Pfizer H1N1 Vaccines Product

Table 94. Pfizer Recent Developments/Updates

Table 95. Mitsubishi Tanabe Pharma Corporation Information

Table 96. Mitsubishi Tanabe Pharma Description and Business Overview

Table 97. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Mitsubishi Tanabe Pharma H1N1 Vaccines Product

Table 99. Mitsubishi Tanabe Pharma Recent Developments/Updates

Table 100. Hualan Biological Engineering Corporation Information

Table 101. Hualan Biological Engineering Description and Business Overview

Table 102. Hualan Biological Engineering H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Hualan Biological Engineering H1N1 Vaccines Product

Table 104. Hualan Biological Engineering Recent Developments/Updates

Table 105. Cipla Corporation Information

Table 106. Cipla Description and Business Overview

Table 107. Cipla H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Cipla H1N1 Vaccines Product

Table 109. Cipla Recent Developments/Updates

Table 110. Merck Corporation Information

Table 111. Merck Description and Business Overview

Table 112. Merck H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Merck H1N1 Vaccines Product

Table 114. Merck Recent Developments/Updates

Table 115. Sinovac Biotech Corporation Information

Table 116. Sinovac Biotech Description and Business Overview

Table 117. Sinovac Biotech H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Sinovac Biotech H1N1 Vaccines Product

Table 119. Sinovac Biotech Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. H1N1 Vaccines Distributors List

Table 123. H1N1 Vaccines Customers List

Table 124. H1N1 Vaccines Market Trends

Table 125. H1N1 Vaccines Market Drivers

Table 126. H1N1 Vaccines Market Challenges

Table 127. H1N1 Vaccines Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of H1N1 Vaccines

Figure 2. Global H1N1 Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global H1N1 Vaccines Market Share by Type in 2023 & 2030

Figure 4. Intramuscular Vaccines Product Picture

Figure 5. Intranasal Vaccines Product Picture

Figure 6. Intradermal Vaccines Product Picture

Figure 7. Global H1N1 Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global H1N1 Vaccines Market Share by Application in 2023 & 2030

Figure 9. Influenza

Figure 10. Meningococcal

Figure 11. Cervical Cancer

Figure 12. Pneumococcal

Figure 13. Hepatitis

Figure 14. Measles

Figure 15. Mumps

Figure 16. Rubella

Figure 17. Others

Figure 18. Global H1N1 Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global H1N1 Vaccines Market Size (2019-2030) & (US$ Million)

Figure 20. Global H1N1 Vaccines Sales (2019-2030) & (K Units)

Figure 21. Global H1N1 Vaccines Average Price (USD/Unit) & (2019-2030)

Figure 22. H1N1 Vaccines Report Years Considered

Figure 23. H1N1 Vaccines Sales Share by Manufacturers in 2023

Figure 24. Global H1N1 Vaccines Revenue Share by Manufacturers in 2023

Figure 25. The Global 5 and 10 Largest H1N1 Vaccines Players: Market Share by Revenue in 2023

Figure 26. H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 27. Global H1N1 Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 28. North America H1N1 Vaccines Sales Market Share by Country (2019-2030)

Figure 29. North America H1N1 Vaccines Revenue Market Share by Country (2019-2030)

Figure 30. U.S. H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Canada H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Europe H1N1 Vaccines Sales Market Share by Country (2019-2030)

Figure 33. Europe H1N1 Vaccines Revenue Market Share by Country (2019-2030)

Figure 34. Germany H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. France H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. U.K. H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Italy H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Russia H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Asia Pacific H1N1 Vaccines Sales Market Share by Region (2019-2030)

Figure 40. Asia Pacific H1N1 Vaccines Revenue Market Share by Region (2019-2030)

Figure 41. China H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Japan H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. South Korea H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. India H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Australia H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Taiwan H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Indonesia H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Thailand H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Malaysia H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Philippines H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Latin America H1N1 Vaccines Sales Market Share by Country (2019-2030)

Figure 52. Latin America H1N1 Vaccines Revenue Market Share by Country (2019-2030)

Figure 53. Mexico H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Brazil H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Argentina H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Middle East & Africa H1N1 Vaccines Sales Market Share by Country (2019-2030)

Figure 57. Middle East & Africa H1N1 Vaccines Revenue Market Share by Country (2019-2030)

Figure 58. Turkey H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Saudi Arabia H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 60. U.A.E H1N1 Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 61. Global Sales Market Share of H1N1 Vaccines by Type (2019-2030)

Figure 62. Global Revenue Market Share of H1N1 Vaccines by Type (2019-2030)

Figure 63. Global H1N1 Vaccines Price (USD/Unit) by Type (2019-2030)

Figure 64. Global Sales Market Share of H1N1 Vaccines by Application (2019-2030)

Figure 65. Global Revenue Market Share of H1N1 Vaccines by Application (2019-2030)

Figure 66. Global H1N1 Vaccines Price (USD/Unit) by Application (2019-2030)

Figure 67. H1N1 Vaccines Value Chain

Figure 68. H1N1 Vaccines Production Process

Figure 69. Channels of Distribution (Direct Vs Distribution)

Figure 70. Distributors Profiles

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions